Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma.

circRNA expression glioblastoma lncRNA polymorphism

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 04 11 2020
accepted: 22 12 2020
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

Glioblastoma is the utmost aggressive diffuse kind of glioma which is originated from astrocytes, neural stem cells or progenitors. This malignant tumor has a poor survival rate. A number of genetic aberrations and somatic mutations have been associated with this kind of cancer. In recent times, the impact of long non-coding RNAs (lncRNAs) in glioblastoma has been underscored by several investigations. Up-regulation of a number of oncogenic lncRNAs such as H19, MALAT1, SNHGs, MIAT, UCA, HIF1A-AS2 and XIST in addition to down-regulation of other tumor suppressor lncRNAs namely GAS5, RNCR3 and NBAT1 indicate the role of these lncRNAs in the pathogenesis of glioblastoma. Several

Identifiants

pubmed: 33634032
doi: 10.3389/fonc.2020.625884
pmc: PMC7901982
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

625884

Informations de copyright

Copyright © 2021 Rezaei, Tamizkar, Sharifi, Taheri and Ghafouri-Fard.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Biother Radiopharm. 2019 Nov;34(9):589-596
pubmed: 31657621
Sci Rep. 2017 Mar 22;7:45029
pubmed: 28327666
Mol Cancer Res. 2018 Oct;16(10):1470-1482
pubmed: 29991527
Cancer Lett. 2015 Apr 1;359(1):75-86
pubmed: 25578780
Mol Cancer. 2018 Nov 23;17(1):166
pubmed: 30470262
J Cell Physiol. 2019 Dec;234(12):23658-23666
pubmed: 31187495
Eur Rev Med Pharmacol Sci. 2018 May;22(9):2715-2722
pubmed: 29771423
Neuro Oncol. 2012 Nov;14(11):1316-24
pubmed: 22952197
Mol Med Rep. 2019 Oct;20(4):3849-3857
pubmed: 31485650
Mol Med Rep. 2019 Aug;20(2):1873-1882
pubmed: 31257517
Oncol Res. 2019 Feb 21;27(3):341-347
pubmed: 29678219
Oncogene. 2017 Jan 19;36(3):318-331
pubmed: 27345398
Cancer Lett. 2021 Feb 1;498:152-164
pubmed: 33130316
Cancer Sci. 2019 May;110(5):1621-1632
pubmed: 30888082
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):262-270
pubmed: 30657584
Mol Ther Nucleic Acids. 2019 Sep 6;17:804-818
pubmed: 31454677
Oncotarget. 2016 Sep 20;7(38):62208-62223
pubmed: 27556696
Mol Cancer. 2017 Nov 13;16(1):171
pubmed: 29132362
Med Sci Monit. 2019 Aug 28;25:6454-6461
pubmed: 31456594
Mol Carcinog. 2018 Jan;57(1):137-141
pubmed: 28926136
PLoS One. 2018 Oct 5;13(10):e0198231
pubmed: 30289954
J Cell Biochem. 2018 Nov;119(11):9081-9089
pubmed: 29953649
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
Oncotarget. 2016 Jul 12;7(28):43835-43851
pubmed: 27270310
Aging (Albany NY). 2019 Mar 5;11(5):1456-1470
pubmed: 30837348
Cancer Chemother Pharmacol. 2018 Apr;81(4):671-678
pubmed: 29397407
J Exp Clin Cancer Res. 2019 Mar 21;38(1):133
pubmed: 30898167
Neoplasma. 2019 Feb 17;66(3):386-396
pubmed: 30784279
Oncotarget. 2015 Jan 1;6(1):537-46
pubmed: 25428914
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Int J Oncol. 2019 Jan;54(1):261-270
pubmed: 30387845
J Neurosurg. 2016 Jan;124(1):129-36
pubmed: 26274999
Oncotarget. 2017 Apr 4;8(14):22783-22799
pubmed: 28187000
Biochem Biophys Res Commun. 2019 Feb 5;509(2):617-623
pubmed: 30606477
Neuroreport. 2019 Aug 14;30(12):817-821
pubmed: 31283714
Biochem Biophys Res Commun. 2018 Jun 7;500(3):569-576
pubmed: 29655792
Cell Death Dis. 2018 Dec 5;9(12):1165
pubmed: 30518750
Mol Ther. 2018 Sep 5;26(9):2267-2281
pubmed: 30037656
J Neuropathol Exp Neurol. 2019 Oct 1;78(10):939-948
pubmed: 31504670
Asian Pac J Cancer Prev. ;18(1):3-9
pubmed: 28239999
Cancer Res. 2018 Sep 1;78(17):4812-4825
pubmed: 29967262
J Neurooncol. 2018 Nov;140(2):225-236
pubmed: 30043319
Biochem Biophys Res Commun. 2018 Feb 5;496(2):712-718
pubmed: 29360452
Cell Physiol Biochem. 2017;42(3):1192-1201
pubmed: 28668966
Environ Sci Pollut Res Int. 2018 Jun;25(18):17674-17681
pubmed: 29671226
Clin Cancer Res. 2018 Feb 1;24(3):684-695
pubmed: 29138341
Neoplasma. 2019 Mar 31;66(4):532-542
pubmed: 30943748
Biochem Cell Biol. 2018 Dec;96(6):832-839
pubmed: 30096248
Biochem Biophys Res Commun. 2018 Jun 2;500(2):518-524
pubmed: 29678575
Oncotarget. 2015 Apr 10;6(10):8353-65
pubmed: 25823657
Eur J Pharmacol. 2019 Nov 15;863:172643
pubmed: 31493405
Cell Rep. 2016 Jun 14;15(11):2500-9
pubmed: 27264189
Acta Neuropathol. 2013 Dec;126(6):931-7
pubmed: 23955565
J Cell Biochem. 2019 Jun;120(6):9056-9062
pubmed: 30525219
Cell Mol Neurobiol. 2016 Nov;36(8):1219-1227
pubmed: 26983719
Int J Biol Markers. 2019 Mar;34(1):69-79
pubmed: 30852975
Mol Cancer Ther. 2016 Dec;15(12):2977-2986
pubmed: 27784795
J Cell Physiol. 2019 Aug;234(8):13807-13819
pubmed: 30663767
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
J Cell Biochem. 2019 Apr;120(4):6698-6708
pubmed: 30506951
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1484-1490
pubmed: 30029885
Cancer Med. 2018 Apr;7(4):1404-1415
pubmed: 29479863
Brain. 2020 Feb 1;143(2):512-530
pubmed: 31891366
Mol Cancer. 2018 Mar 20;17(1):74
pubmed: 29558959
Biochem Biophys Res Commun. 2019 Mar 19;510(4):515-519
pubmed: 30738578
J Hematol Oncol. 2018 Jun 4;11(1):77
pubmed: 29866190
Int J Biol Macromol. 2019 Jun 1;130:878-891
pubmed: 30836187
Cell Death Dis. 2018 Nov 15;9(12):1139
pubmed: 30442884
Cancer Res. 2019 May 15;79(10):2536-2548
pubmed: 30940658
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Aging (Albany NY). 2019 Jun 11;11(11):3811-3823
pubmed: 31186379
Mol Ther Nucleic Acids. 2018 Dec 7;13:431-441
pubmed: 30388617
Oncotarget. 2016 Jul 5;7(27):41737-41747
pubmed: 27229531
Neuro Oncol. 2013 Nov;15 Suppl 2:ii1-56
pubmed: 24137015
Pathol Res Pract. 2019 Aug;215(8):152476
pubmed: 31196742
Nat Commun. 2019 May 3;10(1):2045
pubmed: 31053733
Biochem Biophys Res Commun. 2018 Jun 12;500(4):966-972
pubmed: 29715460
Cell Death Dis. 2019 Mar 13;10(3):246
pubmed: 30867410

Auteurs

Omidvar Rezaei (O)

Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Kasra Honarmand Tamizkar (KH)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Guive Sharifi (G)

Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Taheri (M)

Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Soudeh Ghafouri-Fard (S)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH